• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dyne Therapeutics, Inc. - Common Stock (NQ: DYN )

23.99 -0.31 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,456,239
Open 23.91
Bid (Size) 20.78 (1)
Ask (Size) 26.25 (1)
Prev. Close 24.30
Today's Range 23.65 - 24.90
52wk Range 12.06 - 47.45
Shares Outstanding 58,310,703
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Dyne Therapeutics to Present at Upcoming Investor Conferences
November 07, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+83.69%
+83.69%
1 Month
-19.31%
-19.31%
3 Month
-30.72%
-30.72%
6 Month
-32.67%
-32.67%
1 Year
+89.64%
+89.64%

More News

Read More
Looking Into Dyne Therapeutics's Recent Short Interest
October 22, 2024
Via Benzinga
Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases
October 09, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Peering Into Dyne Therapeutics's Recent Short Interest
September 30, 2024
Via Benzinga
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
September 23, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm
September 20, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 16, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
DYNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Dyne Therapeutics, Inc. on Behalf of Dyne Stockholders and Encourages Investors to Contact the Firm
September 10, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Dyne Therapeutics, Inc. (DYN)
September 09, 2024
From Kirby McInerney LLP
Via Business Wire
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!
September 08, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
DYN Investors Have Opportunity to Join Dyne Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
September 04, 2024
From The Schall Law Firm
Via Business Wire
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
September 03, 2024
Via Benzinga
Exposures Fossil Fuels
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
September 03, 2024
Via Benzinga
Dyne Called Its Sarepta-Rivaling Results 'Unprecedented,' But Its C-Suite Just Fled The Building
September 03, 2024
Via Investor's Business Daily
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via Benzinga
Nasdaq Dips Over 2%; US Construction Spending Falls In July
September 03, 2024
Via Benzinga
Dow Tumbles 1%; ISM Manufacturing PMI Misses Estimates
September 03, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 03, 2024
Via Benzinga
Dyne Therapeutics Announces Key Leadership Appointments
September 03, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts
September 03, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Why Low Volume In S&P 500 Could Be Signaling A Hidden Opportunity?
August 21, 2024
Via Talk Markets
Topics Stocks
Exposures US Equities
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
August 13, 2024
Via Benzinga
Topics Economy
Exposures Interest Rates
DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024
August 12, 2024
Via InvestorPlace
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap